A BusinessWorld Online page on Ozempic safety, but only a title came through. No details on findings or sources were available.
Recap by typeshit. Full story at BusinessWorld Online.
A short post from the endocrinologist pushing back on headlines tying the eye condition to GLP-1 drugs, urging people to look at the data.
Mounjaro became India's top-selling drug in 2025, and a Scroll investigation reports that pharmacies are handing it out without the prescription it requires.
Refused by a doctor for not being overweight, she got doses from an acquaintance and spent two days ill. She writes about why she wanted to be thinner anyway.
The Sunrise health expert says unregulated peptide use can put people in hospital, and in the worst cases leave them needing a new liver.
A basic primer on how GLP-1 works in the body and its role in diabetes and weight management treatment.
The writer credits semaglutide and tirzepatide with real results, but argues medicine risks treating an environmental problem with lifelong medication.
Loading…